These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7335225)

  • 21. CEA--a concept worth exploring.
    O'Brien PH
    Am Surg; 1980 Nov; 46(11):633-6. PubMed ID: 7436141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A time-saving but effective approach to the follow-up of patients after curative surgery for carcinoma of the large bowel.
    Ross AP
    Ann R Coll Surg Engl; 1983 Jan; 65(1):8-10. PubMed ID: 6824311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study.
    Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T
    Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of imaging in abdominopelvic follow-up after resection of colorectal cancer].
    Lassau N; Leclère J; Elias D; Lasser P
    J Chir (Paris); 1997 Jul; 134(2):51-8. PubMed ID: 9378784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tumor markers in malignancies of the gastrointestinal tract].
    von Kleist S; Hohneck A
    Internist (Berl); 1982 Jan; 23(1):10-2. PubMed ID: 6175599
    [No Abstract]   [Full Text] [Related]  

  • 27. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer.
    Irvine T; Scott M; Clark CI
    Colorectal Dis; 2007 Jul; 9(6):527-31. PubMed ID: 17573747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcino-embryonic antigen (CEA) during treatment of recurrent or inoperable tumours of the digestive tract.
    Persijn JP
    Neth J Med; 1982; 25(10):360-4. PubMed ID: 7155240
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures.
    Martin EW; James KK; Hurtubise PE; Catalano P; Minton JP
    Cancer; 1977 Feb; 39(2):440-6. PubMed ID: 837330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Postoperative surveillance of the carcinoembryonic antigen--electronic data processing in monitoring patients with adeno-carcinoma of the gastrointestinal tract (author's transl)].
    Wehrle E
    Methods Inf Med; 1977 Jul; 16(3):182-6. PubMed ID: 904482
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
    Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reresection for gastric carcinoma.
    Scheinin TM; Inberg MV; Linna MI
    Acta Chir Scand; 1968; 134(8):660-6. PubMed ID: 5713449
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prognostic value of circulating immune complexes of carcinoembryonic antigen (CEA) in patients with adenocarcinoma of the gastrointestinal tract (author's transl)].
    Staab HJ; Anderer FA; Stumpf E; Fischer R
    J Clin Chem Clin Biochem; 1980 Mar; 18(3):175-81. PubMed ID: 7381371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preoperative CEA and prognosis in surgery].
    Maceratini R; Di Vona P; Senati E; Tonelli F
    Minerva Chir; 1982 Oct; 37(20):1779-83. PubMed ID: 7177428
    [No Abstract]   [Full Text] [Related]  

  • 36. [The CEA-concentration in plasma of patients with colorectal carcinoma and polyps has been determined by radioimmunoassay (RIA, Z-gel-method)].
    Ziegenbein R; Jacobasch KH; Pilgrim G; Seifart W
    Arch Geschwulstforsch; 1980; 50(2):165-8. PubMed ID: 7436700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [After-care of gastrointestinal malignancies--an evaluation of costs and benefits].
    Zieren HU; Müller JM
    Zentralbl Chir; 1996; 121(3):167-76. PubMed ID: 8867342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative CEA level: a prognostic test in patients with colorectal carcinoma.
    Kohler JP; Simonowitz D; Paloyan D
    Am Surg; 1980 Aug; 46(8):449-52. PubMed ID: 7406353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
    Ahlemann LM; Staab HJ; Anderer FA
    Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
    Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
    J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.